HBK Investments’s AtriCure ATRC Stock Holding History

HBK Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,700	Closed	-$421K	–	631
2019 Q1	$421K	Buy	15,700 +1,100	+8%	+$33.4K	﹤0.01%	864
2018 Q4	$447K	Buy	+14,600	New	+$455K	﹤0.01%	923
2018 Q1	–	Sell	-14,000	Closed	-$255K	–	964
2017 Q4	$255K	Buy	+14,000	New	+$277K	﹤0.01%	887

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

HBK Investments's ATRC Position: Q2 2019 in Review

HBK Investments sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 15,700 shares — an estimated $421K sold.

HBK Investments first reported a position in ATRC in Q4 2017 and held it in 3 quarters. The position peaked at $447K in Q4 2018. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

HBK Investments reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 15,700 AtriCure shares in Q2 2019, an estimated $421K.
HBK Investments first reported a position in AtriCure in Q4 2017 and held it in 3 quarters.
HBK Investments's AtriCure position peaked at $447K in Q4 2018.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.